BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12957285)

  • 1. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias.
    So CW; Lin M; Ayton PM; Chen EH; Cleary ML
    Cancer Cell; 2003 Aug; 4(2):99-110. PubMed ID: 12957285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turning on a dimer: new insights into MLL chimeras.
    Hsu K; Look AT
    Cancer Cell; 2003 Aug; 4(2):81-3. PubMed ID: 12957280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function.
    So CW; Cleary ML
    Mol Cell Biol; 2002 Sep; 22(18):6542-52. PubMed ID: 12192052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLL: a histone methyltransferase disrupted in leukemia.
    Hess JL
    Trends Mol Med; 2004 Oct; 10(10):500-7. PubMed ID: 15464450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common mechanism for oncogenic activation of MLL by forkhead family proteins.
    So CW; Cleary ML
    Blood; 2003 Jan; 101(2):633-9. PubMed ID: 12393557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The small oligomerization domain of gephyrin converts MLL to an oncogene.
    Eguchi M; Eguchi-Ishimae M; Greaves M
    Blood; 2004 May; 103(10):3876-82. PubMed ID: 14751928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis.
    Ono R; Nakajima H; Ozaki K; Kumagai H; Kawashima T; Taki T; Kitamura T; Hayashi Y; Nosaka T
    J Clin Invest; 2005 Apr; 115(4):919-29. PubMed ID: 15761502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9.
    So CW; Karsunky H; Wong P; Weissman IL; Cleary ML
    Blood; 2004 Apr; 103(8):3192-9. PubMed ID: 15070702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimerization of MLL fusion proteins immortalizes hematopoietic cells.
    Martin ME; Milne TA; Bloyer S; Galoian K; Shen W; Gibbs D; Brock HW; Slany R; Hess JL
    Cancer Cell; 2003 Sep; 4(3):197-207. PubMed ID: 14522254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frat2 mediates the oncogenic activation of Rac by MLL fusions.
    Walf-Vorderwülbecke V; de Boer J; Horton SJ; van Amerongen R; Proost N; Berns A; Williams O
    Blood; 2012 Dec; 120(24):4819-28. PubMed ID: 23074275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between EEN and Abi-1, two MLL fusion partners, and synaptojanin and dynamin: implications for leukaemogenesis.
    So CW; So CK; Cheung N; Chew SL; Sham MH; Chan LC
    Leukemia; 2000 Apr; 14(4):594-601. PubMed ID: 10764144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The localization of the HRX/ALL1 protein to specific nuclear subdomains is altered by fusion with its eps15 translocation partner.
    Rogaia D; Grignani F; Carbone R; Riganelli D; LoCoco F; Nakamura T; Croce CM; Di Fiore PP; Pelicci PG
    Cancer Res; 1997 Mar; 57(5):799-802. PubMed ID: 9041173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL.
    DiMartino JF; Miller T; Ayton PM; Landewe T; Hess JL; Cleary ML; Shilatifard A
    Blood; 2000 Dec; 96(12):3887-93. PubMed ID: 11090074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hDOT1L links histone methylation to leukemogenesis.
    Okada Y; Feng Q; Lin Y; Jiang Q; Li Y; Coffield VM; Su L; Xu G; Zhang Y
    Cell; 2005 Apr; 121(2):167-78. PubMed ID: 15851025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A MENage à Trois in leukemia.
    Roudaia L; Speck NA
    Cancer Cell; 2008 Jul; 14(1):3-5. PubMed ID: 18598937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10.
    DiMartino JF; Ayton PM; Chen EH; Naftzger CC; Young BD; Cleary ML
    Blood; 2002 May; 99(10):3780-5. PubMed ID: 11986236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression.
    Yokoyama A; Wang Z; Wysocka J; Sanyal M; Aufiero DJ; Kitabayashi I; Herr W; Cleary ML
    Mol Cell Biol; 2004 Jul; 24(13):5639-49. PubMed ID: 15199122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menin critically links MLL proteins with LEDGF on cancer-associated target genes.
    Yokoyama A; Cleary ML
    Cancer Cell; 2008 Jul; 14(1):36-46. PubMed ID: 18598942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins.
    Ayton PM; Cleary ML
    Oncogene; 2001 Sep; 20(40):5695-707. PubMed ID: 11607819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia.
    Zhu L; Li Q; Wong SH; Huang M; Klein BJ; Shen J; Ikenouye L; Onishi M; Schneidawind D; Buechele C; Hansen L; Duque-Afonso J; Zhu F; Martin GM; Gozani O; Majeti R; Kutateladze TG; Cleary ML
    Cancer Discov; 2016 Jul; 6(7):770-83. PubMed ID: 27154821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.